The Perilous Ethics of Biotech
Sign up for The Nightcrawler Newsletter
A weekly collection of thought-provoking articles on tech, innovation, and long-term investing from Nightview Capital’s Eric Markowitz.
Molecular Biologist Lee Silver acknowledges that there are special bioethical considerations that come into play for those working on biotech—but insists that much of the opposition to the field is based on ignorance and loaded, misleading language.
